share_log

两子公司接近从美商务部“未经核实名单”移除?药明生物:无锡公司已完成检查,上海公司还在等待检查

Are the two subsidiaries close to being removed from the U.S. Department of Commerce's "unverified list"? Wuxi Biologics: Wuxi Company has completed the inspection, and Shanghai Company is still waiting for inspection.

Breakings ·  Jul 5, 2022 16:52
According to media reports, in February this year, Wuxi Wuxi Biologics and Shanghai Wuxi Biologics, two subsidiaries of Wuxi Biologics, were added to the "unverified list" by the US Department of Commerce. It was reported today that Wuxi Biologics may be close to being removed from the list. On the afternoon of July 5, relevant sources of Wuxi Biologics told reporters on Wechat that the inspection of Wuxi Company had just been completed and that everything was going well. At present, the Shanghai Company is waiting for the inspection. It pointed out that the two companies are different legal entities and that one company should also be able to dissolve them separately.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment